Fig. 3From: Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetesCost-Effectiveness Plane, Scatter plots showing the 1000 cases of differences in costs and in the life-year gained from the trial data using 1000 bootstrap replicatesBack to article page